Patent · US Active

Fused pyrimidine derivatives

US10669276B2 · kind B2 · utility

0Cited by

0References

24Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Bjoern Bartels · Schopfheim, DE
Roland Jakob-Roetne · Inzlingen, DE
Anja Limberg · Penzberg, DE
Werner Neidhart · Hagenthal-le-Bas, FR
Hasane Ratni · Habsheim, FR
Sandra Steiner · Atlanta, US
Michael Reutlinger · Glückstadt, DE

Key dates

Filing date	Dec 21, 2018
Grant date	Jun 2, 2020
Priority date	—
Expiry date	Dec 21, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention relates to compounds of formula I, The compounds may be used for the treatment of Alzheimer's disease, cerebral amyloid angiopathy, hereditary cerebral hemorrhage with amyloidosis, Dutch-type (HCHWA-D), multi-infarct dementia, dementia pugilistica or Down syndrome.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.